Evidence map›Paper›PMID 16352553›Full record

ArticleJournal of virology2006

Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Radmila Hrdlicková, Jirí Nehyba, Andrew S Liss, Henry R Bose

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Radmila HrdlickováSection of Molecular Genetics and Microbiology, The University of Texas at Austin, Austin, TX 78712-1095, USA.
Jirí Nehyba
Andrew S Liss
Henry R Bose
The University of Texas at Austin · US

Funding

Transformation by Reticuloendotheliosis VirusR01CA033192 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI BOSE, HENRY R · 1985 to 2011
$3.0M
Mechanism of oncogenesis by Rel/NF-kappaBR01CA098151 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI BOSE, HENRY R · 2003 to 2007
$1.5M
NCI NIH HHS CA098151NCI NIH HHS CA33192NCI NIH HHS R01 CA033192NCI NIH HHS R01 CA098151
6 · The paper itself

Abstract

Telomerase is activated during the transformation of lymphoid cells and fibroblasts by v-Rel, the oncogenic member of the Rel/NF-kappaB family of transcription factors. v-Rel-transformed cell lines have longer telomeres than untransformed chicken lymphoid cells and have high levels of telomerase activity. v-Rel-mediated activation of telomerase is achieved by multiple mechanisms. The expression of the gene encoding the catalytic subunit of telomerase (TERT) was directly upregulated by v-Rel. Moreover, the expression of v-Rel altered the ratio of alternatively spliced and full-length TERT transcripts in favor of the full-length forms. The activation of telomerase by v-Rel in lymphocytes was also accompanied by inactivation of nuclear inhibitors. The inhibition of telomerase activity in v-Rel-transformed cell lines led to apoptosis within 24 h. The expression of v-Rel in a macrophage cell line resulted in elevated levels of reactive oxygen species (ROS), increased telomerase activity, and increased sensitivity to telomerase inhibitors. In contrast, the ectopic expression of TERT decreased the extent of apoptosis induced by ROS. The activation of telomerase by v-Rel may, therefore, partially protect the transformed cells from apoptosis induced by ROS.

Indexed as

Cell Transformation, NeoplasticAnimalsCell Line, TransformedChickensEnzyme ActivationGene Expression Regulation, NeoplasticOncogene Proteins v-relReactive Oxygen SpeciesRNA, NeoplasmTelomeraseTranscription, GeneticOncogene Proteins v-relReactive Oxygen SpeciesRNA, NeoplasmTelomerase

Identifiers

PMID16352553
PMCPMC1317554
OpenAlexW2116688841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.